drugset / Trial / NCT03690947

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

NCT03690947

Phase 4 Completed 72 enrolled Beijing Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate if combination of intravitreal ranibizumab with micropulse laser shows non inferiority compared to intravitreal ranibizumab only in diabetic macular edema.

Timeline

Start
2018-10-01
Primary completion
2021-08-31
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranibizumab Monoclonal antibody Intravitreal